JPH062673B2 - 良性前立腺肥大における排尿困難症を治療するためのナフトピジルの用途 - Google Patents

良性前立腺肥大における排尿困難症を治療するためのナフトピジルの用途

Info

Publication number
JPH062673B2
JPH062673B2 JP2144272A JP14427290A JPH062673B2 JP H062673 B2 JPH062673 B2 JP H062673B2 JP 2144272 A JP2144272 A JP 2144272A JP 14427290 A JP14427290 A JP 14427290A JP H062673 B2 JPH062673 B2 JP H062673B2
Authority
JP
Japan
Prior art keywords
naphthopidil
propyl
hydroxy
benign prostatic
prostatic hyperplasia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2144272A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0324014A (ja
Inventor
スポーナー ギスベルト
ライケ ユーリッヒ
ネルボックーホッホステター ミハエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6382247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH062673(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of JPH0324014A publication Critical patent/JPH0324014A/ja
Publication of JPH062673B2 publication Critical patent/JPH062673B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2144272A 1989-06-07 1990-06-01 良性前立腺肥大における排尿困難症を治療するためのナフトピジルの用途 Expired - Lifetime JPH062673B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3918543A DE3918543A1 (de) 1989-06-07 1989-06-07 Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie
DE3918543.5 1989-06-07

Publications (2)

Publication Number Publication Date
JPH0324014A JPH0324014A (ja) 1991-02-01
JPH062673B2 true JPH062673B2 (ja) 1994-01-12

Family

ID=6382247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2144272A Expired - Lifetime JPH062673B2 (ja) 1989-06-07 1990-06-01 良性前立腺肥大における排尿困難症を治療するためのナフトピジルの用途

Country Status (19)

Country Link
US (1) US5026706A (esLanguage)
EP (1) EP0401653B1 (esLanguage)
JP (1) JPH062673B2 (esLanguage)
KR (1) KR0131452B1 (esLanguage)
AT (1) ATE84416T1 (esLanguage)
AU (1) AU625766B2 (esLanguage)
CA (1) CA2017619C (esLanguage)
DD (1) DD294864A5 (esLanguage)
DE (2) DE3918543A1 (esLanguage)
DK (1) DK0401653T3 (esLanguage)
ES (1) ES2054147T3 (esLanguage)
GR (1) GR3007328T3 (esLanguage)
HK (1) HK46996A (esLanguage)
HU (1) HU206976B (esLanguage)
IE (1) IE62937B1 (esLanguage)
IL (1) IL94601A (esLanguage)
PH (1) PH26690A (esLanguage)
PT (1) PT94268B (esLanguage)
ZA (1) ZA904338B (esLanguage)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
EP1832598A3 (en) 1999-09-30 2008-01-02 Hollis-Eden Pharmaceuticals Inc. Therapeutic treatment of androgen receptor driven conditions
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
BR102012000187A2 (pt) * 2012-01-05 2018-04-10 Univ Rio De Janeiro Derivados n-fenilpiperazínicos antagonistas de adrenoceptores a1a, a1d e de receptores 5-ht1a no tratamento da hiperplasia prostática benigna, composições farmacêuticas contendo os mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Also Published As

Publication number Publication date
HUT54494A (en) 1991-03-28
IL94601A0 (en) 1991-04-15
GR3007328T3 (esLanguage) 1993-07-30
ES2054147T3 (es) 1994-08-01
DD294864A5 (de) 1991-10-17
DE3918543C2 (esLanguage) 1991-06-06
PT94268B (pt) 1997-01-31
KR910000152A (ko) 1991-01-29
DK0401653T3 (da) 1993-03-29
ATE84416T1 (de) 1993-01-15
ZA904338B (en) 1991-03-27
EP0401653B1 (de) 1993-01-13
CA2017619C (en) 1995-06-20
PH26690A (en) 1992-09-15
DE59000748D1 (de) 1993-02-25
JPH0324014A (ja) 1991-02-01
IE62937B1 (en) 1995-03-08
PT94268A (pt) 1991-02-08
IE902014L (en) 1990-12-07
HK46996A (en) 1996-03-22
KR0131452B1 (ko) 1998-04-17
AU5628290A (en) 1990-12-13
IL94601A (en) 1994-06-24
DE3918543A1 (de) 1990-12-13
EP0401653A3 (de) 1991-07-17
AU625766B2 (en) 1992-07-16
CA2017619A1 (en) 1990-12-07
HU206976B (en) 1993-03-01
HU903515D0 (en) 1990-10-28
US5026706A (en) 1991-06-25
EP0401653A2 (de) 1990-12-12

Similar Documents

Publication Publication Date Title
US5441986A (en) Estrogen agonists as remedies for prostate and cardiovascular diseases
RU2123335C1 (ru) Средство для снижения содержания холестерина в крови, фармацевтическая композиция
HUT72313A (en) Pharmaceutical compositions for treating menstrual symptoms and process for their preparation
CZ285128B6 (cs) Orální kapalné prostředky obsahující resinát paroxetinu
JP2009527525A (ja) 尿失禁治療用のベンゾイミダゾロン誘導体
EP0123469B1 (en) Use of fluoxetine for the manufacture of an anti-anxiety agent
JPH05255084A (ja) 経皮的冠動脈形成術後の再狭窄抑制剤
JPH10504572A (ja) ウイルスの複製を阻害する方法
JPH10511962A (ja) 婦人科疾患の治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用
JPH07215858A (ja) 機能障害性子宮出血を抑制する方法
JPH07215865A (ja) 閉経後女性の性欲を増進するための方法
JPS6048924A (ja) 骨粗鬆症治療剤
JPH07196501A (ja) 胸部疾患を抑制するための医薬組成物
JPH062673B2 (ja) 良性前立腺肥大における排尿困難症を治療するためのナフトピジルの用途
CA2321369C (en) Dosing regimens for lasofoxifene
HUT71337A (en) Pharmaceutical compositions for inhibiting turner's syndrome containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
HOLUB et al. Sodium and water diuresis in cirrhotic patients with intractable ascites following chemical inhibition of aldosterone synthesis
US3011945A (en) Phenylcyclopropylamine -10-(omega-aminoalkyl)-phenothiazine ataractic composition
JP2003519182A (ja) 女性化乳房の治療用の製剤
EP0521057A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL USES OF THESE COMPOSITIONS.
JP2008031146A (ja) 咳治療用組成物
JPH07196492A (ja) 体重増加を抑制する、または体重減少を誘発するための医薬組成物
JPH0678233B2 (ja) 抗高血圧症および心臓保護作用を有する医薬調剤
JPWO2004035089A1 (ja) ホルモン依存性癌の治療剤
EP1345599A1 (en) Treatment of obsessive compulsive disorder

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090112

Year of fee payment: 15

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100112

Year of fee payment: 16

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110112

Year of fee payment: 17

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120112

Year of fee payment: 18

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130112

Year of fee payment: 19

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140112

Year of fee payment: 20

EXPY Cancellation because of completion of term